📰 As Proteins News
As Proteins News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from As Proteins. Real-time updates on events, politics, business and more.
March 5, 2023
Cell membrane protrusions called blebs that typically signify the end of life for healthy cells do the opposite for melanoma cells, activating processes in these cells that help them to survive and spread, a UT Southwestern study suggests.
April 26, 2022
Peripheral membrane proteins have the particularity of temporarily binding to cell membranes, a necessary step for them to be able to fulfil their biological function.
February 10, 2022
As a 10-year journey comes to fruition, MUSC Hollings Cancer Center researcher John O'Bryan, Ph.D., and colleagues have demonstrated a new therapeutic way to block a protein that is frequently mutated in cancers.
January 10, 2022
Lawrence Livermore National Laboratory researchers and a multi-institutional team of scientists have developed a highly detailed, machine learning-backed multiscale model revealing the importance of lipids to the signaling dynamics of RAS, a family of proteins whose mutations are linked to numerous cancers.
September 8, 2021
Transmissible to humans. adding s proteins, how the virus attaches to the cell. low and behold they created viruses not found in nature that were more transmissible than what they started. the very definition of gain of function. viruses are more transmissible to human. why is it not gain of function? >> harris: today "new york post" summing up the controversy with a scathing cover. its a real wu done it based on the wuhan lab. >> dr. paul is schooling dr. fauci at this point. it ends up dr. pau...
August 11, 2021
Weltweit werden zwar immer mehr Menschen gegen die durch das Coronavirus SARS-CoV-2 verursachte Krankheit COVID-19 geimpft, doch Impfungen allein werden wohl nicht reichen, um die Pandemie zu beenden. Wichtig sind auch Medikamente, die gegen die Erkrankung eingesetzt werden können. Hier sind Forschende nun wohl einen Schritt weiter gekommen. Sie haben möglicherweise eine Schwachstelle des Virus gefunden.
June 10, 2021
Emerging Insights about RAS-Addicted Cancers, Drug Resistance and Treatment StrategiesREDWOOD CITY, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company developing targeted therapies to inhibit frontier targets in RAS-addicted cancers, today announced that it will host a Science Talk webcast to highlight learnings from recent preclinical and clinical studies of RAS inhibitors. The webcast, to be held at 4:00 p.m. Eastern
June 3, 2021
Almost all attempts to use the Ras protein as a point of attack for medications have so far failed. New knowledge concerning its structure is raising hopes of options in the development of medications.